ストックスクリーナーアプリを入手
23.36
0.26%
-0.06
アフターアワーズ：
23.36
Pacira Biosciences Inc (PCRX) 最新ニュース
Pacira (NASDAQ: PCRX) investors reelect board nominees and add 800,000 ESPP shares - Stock Titan
[144] Pacira BioSciences, Inc. SEC Filing - Stock Titan
Biotech company shareholders elect Chris Christie in rejecting activist investor's slate - The Business Journals
Shareholders elect Pacira's three board picks in preliminary vote - Stock Titan
Pacira shareholders lobbied by hedge fund board nominees - MSN
Technical Reactions to PCRX Trends in Macro Strategies - Stock Traders Daily
Pacira BioSciences CAO Kristen Williams sells $228,467 in stock By Investing.com - Investing.com Canada
Pacira BioSciences CAO Kristen Williams sells $228,467 in stock - Investing.com
Pacira (PCRX) SVP has 3,187 shares withheld for tax obligations - Stock Titan
Pacira BioSciences (NASDAQ: PCRX) CMO has 4,728 shares withheld for taxes - Stock Titan
Pacira (PCRX) CAO sells 10,259 shares under pre-set 10b5-1 trading plan - Stock Titan
Pacira BioSciences Reminds Stockholders to Vote the BLUE Proxy Card "FOR" the Election of the Company's Highly Qualified Nominees Ahead of its Annual Meeting - Yahoo Finance
Pacira Stock Waits for June 9 Board Fight - Bez Kabli
Pacira BioSciences' CFO Sold 12,941 Shares for $326,000 Before Its Q1 Earnings Release - AOL.com
Pacira Biosciences Inc (NASDAQ:PCRX) Emerges as a Deep Value Opportunity with Strong Financial Health - ChartMill
Press Release: Pacira BioSciences Highlights Leading Independent Proxy Advisory Firm ISS' Recommendation to Vote "FOR" All of Pacira's Director Nominees - Moomoo
Pacira BioSciences, Inc.Common Stock (NQ: PCRX - FinancialContent
Pacira (PCRX): Glass Lewis Recommends Stockholder Votes - GuruFocus
Glass Lewis Backs Pacira BioSciences Director Slate Ahead of Key VoteRevenue Guidance Update - The Legal Advocate
[DFAN14A] Pacira BioSciences, Inc. SEC Filing - Stock Titan
Pacira Biosciences IncProxy Advisory Firm Glass Lewis Recommends Stockholders Vote "For" All Of Pacira's Director Nominees - TradingView
Pacira BioSciences, Inc. Receives Glass Lewis Endorsement for Director Nominees Ahead of 2026 Annual Meeting - Quiver Quantitative
Leading Independent Proxy Advisory Firm Glass Lewis Recommends Stockholders Vote 'FOR” All of Pacira’s Director Nominees - The Manila Times
Leading Independent Proxy Advisory Firm Glass Lewis - GlobeNewswire
DOMA Perpetual Capital Provides Information to Shareholders of Pacira BioSciences - marketscreener.com
DOMA PERPETUAL CAPITAL MANAGEMENT QUESTIONS WHY SHAREHOLDERS SHOULD VOTE TO CONTINUE WITH A BOARD THAT HAS OVERSEEN A DECADE OF VALUE DESTRUCTION - Quantisnow
Pacira study links EXPAREL to lower opioid use after surgery - Investing.com UK
Considering Pacira Biosciences Inc (PCRX) Stock After Q1 Report? Check the Details - Yahoo Finance
Pacira BioSciences urges shareholders to suppor... | Pluang – Crypto, Stocks, Gold & Funds - Pluang
Pacira (PCRX) Highlights Positive Study Outcomes on Exparel Usage - GuruFocus
Pacira BioSciences Mails Letter to Stockholders Reiterating Confidence in the Company’s Strategic Direction and Highly Qualified Nominees - The Manila Times
Pacira BioSciences Mails Letter to Stockholders Reiterating - GlobeNewswire
symbol__ Stock Quote Price and Forecast - CNN
Pacira BioSciences Says Exparel Linked to Lower Opioid Use, Healthcare Costs - Moomoo
Pacira study links EXPAREL to lower opioid use after surgery By Investing.com - Investing.com Australia
Pacira BioSciences Reports Real-World Study Showing EXPAREL® Use Was Associated with Reduced Opioid Use and Healthcare Costs in Patients Undergoing Total Shoulder Arthroplasty - The Manila Times
Pacira BioSciences Reports Real-World Study Showing - GlobeNewswire
Pacira (PCRX) Addresses Stockholder Concerns Over Misleading Cla - GuruFocus
Pacira BioSciences Sets the Record Straight Regarding DOMA’s Misleading Statements About Pacira’s Intellectual Property Strategy - The Manila Times
Pacira BioSciences Sets the Record Straight Regarding - GlobeNewswire
Trading the Move, Not the Narrative: (PCRX) Edition - Stock Traders Daily
A LETTER TO PACIRA BIOSCIENCES SHAREHOLDERS FROM DOMA PERPETUAL CAPITAL MANAGEMENT LLC - Sahm
PCRX Stock Chart | PACIRA BIOSCIENCES INC (NASDAQ:PCRX) - ChartMill
DOMA Perpetual Capital Issues a Press Release to Pacira BioSciences Shareholders - marketscreener.com
Doma Perpetual urges Pacira BioSciences shareholders to judge sale price adequacy - marketscreener.com
Doma Perpetual Urges Pacira Biosciences Shareholders To Judge Sale Price Adequacy - TradingView
DOMA (PCRX) pushes for 3 board seats; discloses ~2.78M shares - Stock Titan
DOMA Perpetual Issues a Press Release to Shareholders of Pacira BioSciences - marketscreener.com
PCRX: DOMA Capital Advocates for Change in Pacira BioSciences Bo - GuruFocus
Independent candidates urge Pacira investors to back board change - Stock Titan
Pacira Biosciences Inc at RBC Capital Markets Global Healthcare Conference Transcript - GuruFocus
Pacira BioSciences Issues Investor Presentation for Shareholders - marketscreener.com
3.72%
0.45%
大文字化:
|
ボリューム (24 時間):